Merck KGaA Shares Jump on Expected Return to Sales Growth in 2024
By Adria Calatayud
Shares of Germany's Merck KGaA rose after the company forecast a return to organic sales growth next year, supported by recovering demand for semiconductor materials and abating Covid-19 headwinds.
At 0749 GMT on Thursday, Merck's shares traded 5.4% higher at EUR153.40.
The life-sciences and electronics group confirmed it expects a broadly stable top-line performance this year, with sales ranging from a 2% fall to a 2% rise and resulting in total net sales of 20.5 billion euros and 21.9 billion euros ($21.60 billion-$23.08 billion).
Analysts polled by FactSet expect Merck's sales to be EUR21.33 billion this year, growing to EUR22.46 billion in 2024.
Merck said weakening Covid-19 sales should be less of a headwind next year than in 2023 for its life-sciences segment, while the semiconductor-material market served by its electronics segment is expected to recover incrementally in 2024.
The company also reiterated medium-term targets for its division and said exposure to structural trends give it confidence in continuing to grow beyond 2025.
Write to Adria Calatayud at adria.calatayud@dowjones.com
(END) Dow Jones Newswires
October 19, 2023 04:07 ET (08:07 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
Six Sports Betting and iGaming Stocks Trading at a Discount
-
4 Predictions for Stocks and the Economy for the Second Half of 2024
-
What Broadening Rally? AI Stocks Dominate Again In Q2
-
After Earnings, Is Nike Stock a Buy, a Sell, or Fairly Valued?
-
Worst-Performing Stock ETFs of the Quarter
-
Top-Performing Stock ETFs of the Quarter
-
Q2 In Review and Q3 2024 Market Outlook
-
5 Stocks to Buy for 3Q 2024
-
Industrials: Sector Offers Investment Opportunities as Performance Lags Broader Market
-
Consumer Defensives: Even Amid Macro Pressures, Deals Permeate the Landscape
-
33 Undervalued Stocks
-
Utilities: Can the Stocks Keep the Rally Going?
-
Basic Materials: Following Index Decline, We See Many Long-Term Opportunities
-
Healthcare: Valuations Look Attractive In Most Industries
-
Financial Services: Amid Uncertainties, We See the Most Value In Banks and Credit Services
-
Consumer Cyclicals: Even With Anxiety Over Spending, We See Attractive Valuations